Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases
Open accessThe DOI matches its Crossref record; 110 of the 111 references it cites were found in a registry or an index.
Abstract
The suprachoroidal space (SCS), a potential space between the sclera and choroid, is becoming an applicable method to deliver therapeutics to the back of the eye. In recent years, a vast amount of research in the field has been carried out, with new discoveries in different areas of interest, such as imaging, drug delivery methods, pharmacokinetics, pharmacotherapies in preclinical and clinical trials and advanced therapies. The SCS can be visualized via advanced techniques of optical coherence tomography (OCT) in eyes with different pathologies, and even in healthy eyes. Drugs can be delivered easily and safely via hollow microneedles fitted to the length of the approximate thickness of the sclera. SCS injections were found to reach greater baseline concentrations in the target layers compared to intravitreal (IVT) injection, while agent clearance was faster with highly aqueous soluble molecules. Clinical trials with SCS injection of triamcinolone acetonide (TA) were executed with promising findings for patients with noninfectious uveitis (NIU), NIU implicated with macular edema and diabetic macular edema (DME). Gene therapy is evolving rapidly with viral and non-viral vectors that were found to be safe and efficient in preclinical trials. Here, we review these novel different aspects and new developments in clinical treatment of the posterior segment of the eye.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Different ocular drug administration routs; (1) topical route, (2) subconjunctival route, (3) suprachoroidal route with microcannula and microneedle, (4) subretinal route and (5) intravitreal injection. Reproduced from [5], CC BY 4.0 license, Published by MDPI 2021.](https://figures.cochat.ai/paper-figures/bc7286a15e24443f8f64ce0b2cfb23bb/drug-delivery-via-the-suprachoroidal-space-for-the-treatment-of-retinal-diseases-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This injection requires a skilled surgeon and must be performed in an operating room. Procedure-related adverse events include suprachoroidal hemorrhage, endophthalmitis, choroidal tears, changes in choroidal blood flow, inflammation, and retinal detachment.131”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [131]
In the citing paper
“Suprachoroidal injections, administered between the choroid and sclera, do not require vitreoretinal surgeries, and show better bioavailability than intravitreal injections.1,131,132”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hydrogel: Preparation, characterization, and applications: A review
Ahmed, E. M. (2015) · Journal of Advanced Research · doi:10.1016/j.jare.2013.07.006 · Cited by 5,800 · cited 1×
“A hydrogel is a network of crosslinked polymer chains that are hydrophilic and capable of holding large amounts of water due to their structure [60].”
BackgroundGlobal estimates of visual impairment: 2010
Pascolini, D., & Mariotti, S. P. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300539 · Cited by 3,763
Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography
Spaide, R. F., Koizumi, H., & Pozonni, M. C. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.05.032 · Cited by 2,180
Hyaluronic Acid Hydrogels for Biomedical Applications
Burdick, J. A., & Prestwich, G. D. (2011) · Advanced Materials · doi:10.1002/adma.201003963 · Cited by 2,139 · cited 1×
“Hyaluronic acid (HA) hydrogels are used frequently for sustained ocular drug delivery [61].”
BackgroundMicroneedles: A smart approach and increasing potential for transdermal drug delivery system
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.078 · Cited by 1,260 · cited 1×
“They have an empty space inside which is filled with the drug dispersion or solution and have holes at the tips (Figure 3) [41].”
BackgroundViral and nonviral delivery systems for gene delivery
Nayerossadat, N., Maedeh, T., & Ali, P. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.98152 · Cited by 858 · cited 1×
“Viral gene delivery utilizes the ability of a virus to inject its DNA into a host cell and to deliver the desired genetic material into the nucleus for replication [90].”
BackgroundPharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693 · cited 2×
“The SCS is the potential space lying between the sclera and choroid [7].”
BackgroundA combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414 · cited 1×
“IVT injection is easy to administer and can be performed in an office setting; however, it does not target a specific area and has adverse effects, including endophthalmitis, elevated intraocular pressure (IOP) and cataract progression [6].”
BackgroundSuprachoroidal drug delivery to the back of the eye using hollow microneedles
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0271-y · Cited by 330 · cited 1×
“[11] showed the applicability of hollow microneedles for injecting drugs into the SCS.”
Background
Research works printed but not linked: 2
- Michalewska, 2013, Retinal Physician—Going Deeper and Wider, Retin. Physician, 10, 42
- Barakat, 2021, Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study, Ophthalmology, 5, 60
Cited by
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q. (2022) · Cells · doi:10.3390/cells11213362 · Cited by 300
Long-acting microneedle formulations
Vora, L. K., Sabri, A. H., Naser, Y., Himawan, A., Hutton, A. R. J., Anjani, Q. K., Volpe-Zanutto, F., Mishra, D., Li, M., Rodgers, A. M., et al. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115055 · Cited by 166
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145
Bairagi, R. D., Reon, R. R., Hasan, M. M., Sarker, S. K., Debnath, D., Rahman, M. T., Rahman, S., Islam, M. A., Siddique, M. A. T., Bokshi, B., et al. (2025) · Discover Nano · doi:10.1186/s11671-025-04234-6 · Cited by 92
“Moreover, the use of collagen shields has become important in transferring plasmid DNA into the bleb following glaucoma surgery to control wound healing [275].”
Suprachoroidal Injection: A Novel Approach for Targeted Drug Delivery
Wu, K. Y., Fujioka, J. K., Gholamian, T., Zaharia, M., & Tran, S. D. (2023) · Pharmaceuticals · doi:10.3390/ph16091241 · Cited by 69
“Hollow microneedles are miniature devices used primarily for transdermal drug delivery [7,13].”
BackgroundMethodInfluential
Metadata
- Authors
- Naftali Ben Haim, L., & Moisseiev, E.
- Affiliations
- Department of Ophthalmology, Meir Medical Center, Kfar Saba, 59 Tshernichovsky St., Kfar Saba 4428164, Israel
- Tel Aviv University (IL)
- ORCID
- Moisseiev, Elad
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2021-06-26
- Volume
- 13
- Issue
- 7
- Pages
- 967
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC8309112
- OpenAlex
- W3173820223
- Cited by
- 68
- References
- 111
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 11 · 2021: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- suprachoroidal space, drug delivery, retinal disease, sclera, choroid, hollow microneedles, intravitreal injection, triamcinolone acetonide, non-infectious uveitis, macular edema, diabetic macular edema, gene therapy, viral vectors, non-viral vectors, posterior segment of the eye, pharmacokinetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases. https://app.cochat.ai/papers/10.3390/pharmaceutics13070967
- The paper
- Naftali Ben Haim, L., & Moisseiev, E. (2021). Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases. Pharmaceutics. https://doi.org/10.3390/pharmaceutics13070967
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.